# Awagin Consulting

> Awagin Consulting is a VC fund in Tokushima backing Health Care and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Tokushima, Japan
- Total investments: 1
- Last investment: Jun 2020
- Lead investor: 0%
- Last updated: Aug 2026

Awagin Consulting is a VC fund in Tokushima focused on Health Care and Biotechnology. Awagin Consulting provides management improvement support consulting services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Business Information Systems | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Setsuro Tech | Seturotech is a biotechnology venture company established on February 22, 2017 by Tatsuya Takemoto (PI: Principal Investigator) of the University of Tokushima as a venture from Tokushima University. In 2015, Takemoto and Masakazu Hashimoto (Osaka University) developed a simple and highly efficient method for producing genetically modified(genome-edited) mice using CRISPR / Cas9, and filed a patent application for the technology. The technology is called fertilized egg electroporation (GEEP method), a technology that introduces molecules required for genome editing by CRISPR into fertilized eggs at high throughput by the power of electricity (electroporation). Using this technology, Seturotech will start from the production and sale of genetically modified mice, and will become a fundamental company providing all genetically modified animals, anticipating the future use of genetically modified animals in industry. | $4.3M | Series A | Jun 02, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [A-Five](https://shizune.co/investors/profile/agriculture-forestry-and-fisheries-fund-corporation-for-innovation-value-chain-and-expansion-japan) — VC Fund, 1 deal together
- [Miraidoa](https://shizune.co/investors/profile/future-venture-capital) — VC Fund, 1 deal together
- Kagawa Bank — VC Fund, 1 deal together
- Kitaoka Group — VC Fund, 1 deal together
- Nakayama — VC Fund, 1 deal together
- [SBI Investment](https://shizune.co/investors/profile/sbi-investment-2) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Awagin Consulting invest in?

Awagin Consulting invests primarily in Health Care, Biotechnology and Business Information Systems startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Awagin Consulting last invest?

The most recent investment recorded for Awagin Consulting closed in Jun 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co